Share This Page
Bulk Pharmaceutical API Sources for GLYCINE
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for GLYCINE
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| ChemExper Chemical Directory | ⤷ Start Trial | sJX`BDdvu@@ | ⤷ Start Trial |
| Specs | ⤷ Start Trial | AB-131/40217813 | ⤷ Start Trial |
| Sigma-Aldrich | ⤷ Start Trial | 410225_SIAL | ⤷ Start Trial |
| Sigma-Aldrich | ⤷ Start Trial | G7126_SIGMA | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for Glycine
Glycine is a non-essential amino acid used in pharmaceutical, nutraceutical, and food industries. Its bulk sourcing involves chemical synthesis, fermentation, or extraction from natural sources. Major API producers and suppliers operate globally, offering varying qualities and certifications.
What Are the Major API Sourcing Methods for Glycine?
Chemical Synthesis
- Produces synthetic glycine via routes such as:
- Chloramine-T oxidation of amino acetic acid.
- Strecker synthesis involving aldehydes and ammonia.
- Advantages: Consistent chemical purity, scalable.
- Drawbacks: Potential environmental concerns, higher cost.
Fermentation
- Uses microbial fermentation of glucose or other substrates.
- Produces biologically equivalent glycine.
- Advantages: Lower environmental impact, high purity.
- Drawbacks: Longer production cycles, complex control processes.
Extraction
- Derived from natural protein hydrolysis (e.g., collagen or gelatin).
- Less common for bulk APIs due to variability and complexity.
Global API Suppliers for Glycine
| Supplier | Location | Certification | Production Method | Annual Production Capacity (Approx.) | Notes |
|---|---|---|---|---|---|
| Ajinomoto Co. | Japan | GMP, ISO 9001 | Fermentation | 10,000+ tons | Leading global producer, high purity |
| Evonik Industries | Germany | GMP, ISO | Chemical synthesis | 5,000+ tons | Focus on pharmaceutical grade |
| Shaanxi Fuhuiyuan Bio-Tech | China | GMP, ISO | Fermentation | 3,000+ tons | Cost competitive, growing export |
| Tokyo Chemical Industry | Japan | GMP, ISO | Chemical synthesis | Not specified | Provides industry-grade APIs |
| CJ CheilJedang | South Korea | GMP, ISO | Fermentation | Data unavailable | Focus on high-quality amino acids |
Notable API Quality Standards and Certifications
- GMP (Good Manufacturing Practice): Required for pharmaceutical APIs.
- ISO 9001: Quality management certification.
- FDA Registration: Necessary for US market.
- EU Good Manufacturing Practice: Certification for European markets.
Regional Market Dynamics
- Asia-Pacific: Largest production hub, led by China and India. Cost advantages dominate.
- Europe: Focuses on high-quality, sterile, pharmaceutical-grade glycine.
- North America: Relying on imports; compliance with FDA standards critical.
Quality Considerations
- Purity levels typically above 99.5% for pharmaceutical use.
- Residual ammonia, chlorinated compounds, or by-products must be within limits.
- Certificates of Analysis (COA) mandated for batch release.
Supply Chain Considerations
- Lead times vary from weeks (for existing stocks) to months (for custom orders).
- Suppliers maintaining cold chain or secure storage for sensitive APIs.
- Long-term contracts preferred for stable supply.
Regulatory and Trade Implications
- Import/export tariffs influence region-to-region costs.
- API suppliers often register with regulatory authorities like the FDA or EMA.
- Pharmacopoeia standards (USP, Ph. Eur., JP) dictate acceptable specifications.
Supply Risks and Market Trends
- API supply chains vulnerable to geopolitical shifts, trade restrictions.
- Increased investment in fermentation technology for sustainability.
- Growing demand for pharmaceutical-grade glycine, especially in Asia-Pacific.
Key Takeaways
- Major suppliers include Ajinomoto, Evonik, Shaanxi Fuhuiyuan, Tokyo Chemical Industry, and CJ CheilJedang.
- The primary production methods are fermentation and chemical synthesis, each with distinct cost and purity profiles.
- Certification standards such as GMP and ISO are crucial for pharmaceutical APIs.
- Geographic hubs influence quality, cost, and supply chain stability.
- Regulatory compliance remains essential for market access, with increasingly stringent standards shaping supply dynamics.
FAQs
1. What is the main difference between synthetic and fermentation-produced glycine?
Synthetic glycine is produced chemically, offering high purity and scalability. Fermentation uses microbial processes, which are potentially more sustainable but may involve longer production times.
2. Which regions dominate glycine API manufacturing?
Asia-Pacific leads, especially China and India. Europe and North America focus on quality-certified, pharmaceutical-grade glycine.
3. What certifications are required for pharmaceutical API suppliers?
GMP certification is mandatory; ISO 9001 is common for quality management. Suppliers targeting US markets often seek FDA registration.
4. How does supply chain stability affect glycine availability?
Supply chains vulnerable to geopolitical risks, raw material availability, or regulatory changes can impact lead times and prices.
5. Are natural extraction methods viable for bulk API supply?
Extraction from natural sources is less common due to variability in raw material composition, cost, and complexity compared to fermentation and chemical synthesis.
References
[1] European Pharmacopoeia. (2021). Glycine monograph.
[2] Ajinomoto Co. Inc. (2022). Product catalog.
[3] Evonik Industries. (2022). Amino acids manufacturing overview.
[4] U.S. Food and Drug Administration. (2022). API registration requirements.
[5] China Food and Drug Administration. (2022). API production standards.
More… ↓
